PRINCETON, NJ – (December 6, 2019) Systech announced today that it has been selected as a finalist in this year’s Fierce Innovation Awards, a peer-reviewed awards program from the publisher of FierceBiotech and FiercePharma. Systech is being recognized in the Technology Innovation category for the Systech Brand Protection Suite™, an industry-leading software solution that ensures products are authentic, safe and connected across the supply chain—from manufacturer to consumer. 

The awards competition highlights companies that demonstrate pioneering technologies and new services that showcase outstanding innovation currently driving improvements and transformation across biotech and pharmaceutical industries. The Systech Brand Protection Suite has changed the way brands combat threats of counterfeiting and supply chain diversion. This market-disrupting solution uses an existing package barcode to create a fail-safe product authenticity and connectivity measure—deriving a unique digital e-Fingerprint® for each package.

“Being a finalist in the Technology Innovation category is incredibly rewarding and speaks to Systech’s culture 30-plus years of innovation in serialization, track-and-trace and product authentication solutions,” said Ara Ohanian, CEO of Systech.

Finalist applications were reviewed by an exclusive panel of executives from major biotech and pharma companies including Astellas, PPD Corporate Development & Strategy, Signant Health, Medidata Solutions, Accenture’s Global Applied Life Sciences Solutions Practice, Angelica Therapeutics, (NIHR) Clinical Research Network, Biotech Research Group, Ostuaka Pharmaceuticals, AstraZeneca and BrightInsight, a Flex Company. 

Winners will be announced in the 2019 Innovation Report set to publish by FierceHealthcare on Thursday, December 18th. 

Media Contact:

Jefferson Barr, VP Marketing
+1 609-235-8446
Jefferson.Barr@SystechOne.com

WEBINAR | June 6th at 10am EST/4pm CET
IDC-logo

Pharma supply chain insights to action

with IDC Analysts

Exclusive data-driven session on “Solving the Critical Pharmaceutical Supply Chain Challenges” with the latest research findings on industry trends and innovative technologies to address market needs.